INTRABIO - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
79232153
Word Mark
INTRABIO
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2019-01-10
Filing Date
2018-02-14
Mark Drawing
4000 - Standard character mark
Typeset
Law Office Assigned Location Code
M20
Employee Name
SEVERSON, JUSTIN
Statements
Goods and Services
Pharmaceutical preparations; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for the prevention of diseases of the nervous system; pharmaceutical preparations for treating sensory organ disorders; pharmaceutical preparations for use in the prevention and treatment of neurodegenerative diseases; pharmaceutical preparations for use in the prevention and treatment of neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; drugs for medical purposes; drugs for medical purposes, namely, the prevention and treatment of neurodegenerative diseases; drugs for medical purposes, namely, the prevention and treatment of neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; reagents for use in medical genetic testing; diagnostic reagents for medical laboratory use; diagnostic reagents for medical laboratory use, namely, use in the detection and identification of neurodegenerative diseases; diagnostic reagents for medical laboratory use, namely, use in the detection and identification of neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; amino acid preparations for medical purposes; amino acid preparations for pharmaceutical use
Goods and Services
Scientific and technological services and research and design relating thereto; industrial analysis and research services; scientific and technological services and research in the field of neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; industrial analysis and research services related to neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy, design and development of computer hardware and software related to assays; clinical trials; conducting clinical trials for pharmaceutical products; conducting clinical trials for neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; medical laboratories for research related to neurodegenerative diseases, namely, lysosomal storage disorders, niemann-pick disease, alzheimer's disease, parkinson's disease, prion disease, motor neurone disease, huntington's disease, spinocerebellar ataxia and spinal muscular atrophy; providing information about the results of clinical trials for pharmaceutical products; clinical research; medical laboratories; research relating to molecular sciences; medical research; genetic research; research in the field of gene therapy; biopharmaceutical research for development of targeted therapies for use in the treatment of carcinomas and neurodegenerative diseases; scientific, biochemical, research and development services in the field of neurodegenerative diseases; providing scientific information in the field of medical disorders and their treatment; pharmaceutical drug development services
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-05-21
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-05-21
Primary Code
042
Correspondences
Name
Cooley (UK) LLP
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1401943
International Registration Date
2018-02-14
International Publication Date
2018-05-17
International Renewal Date
2028-02-14
Auto Protection Date
2019-11-17
International Status
001 - Request for extension of protection established
International Status Date
2018-05-17
Priority Claimed In
True
Priority Claimed Date
2017-08-17
First Refusal In
True
Trademark Events
Event Date | Event Description |
2018-05-17 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2018-05-21 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-05-25 | APPLICATION FILING RECEIPT MAILED |
2018-05-30 | ASSIGNED TO EXAMINER |
2018-06-06 | NON-FINAL ACTION WRITTEN |
2018-06-07 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2018-06-14 | REFUSAL PROCESSED BY MPU |
2018-06-14 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2018-06-30 | REFUSAL PROCESSED BY IB |
2019-01-10 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
2019-01-11 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
2019-10-23 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
2019-10-23 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2019-11-08 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
2020-01-10 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2020-01-10 | FINAL DISPOSITION NOTICE SENT TO IB |
2020-01-31 | FINAL DECISION TRANSACTION PROCESSED BY IB |